Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. / Egan, Aoife M; Vellinga, Akke; Harreiter, Jürgen; Simmons, David; Desoye, Gernot; Corcoy, Rosa; Adelantado, Juan M; Devlieger, Roland; Van Assche, Andre; Galjaard, Sander; Damm, Peter; Mathiesen, Elisabeth R; Jensen, Dorte M; Andersen, Liselotte; Lapolla, Annuziata; Dalfrà, Maria G; Bertolotto, Alessandra; Mantaj, Urszula; Wender-Ozegowska, Ewa; Zawiejska, Agnieszka; Hill, David; Jelsma, Judith G M; Snoek, Frank J; Worda, Christof; Bancher-Todesca, Dagmar; van Poppel, Mireille N M; Kautzky-Willer, Alexandra; Dunne, Fidelma P; DALI Core Investigator Group.

In: Diabetologia, Vol. 60, No. 10, 10.2017, p. 1913-1921.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Egan, AM, Vellinga, A, Harreiter, J, Simmons, D, Desoye, G, Corcoy, R, Adelantado, JM, Devlieger, R, Van Assche, A, Galjaard, S, Damm, P, Mathiesen, ER, Jensen, DM, Andersen, L, Lapolla, A, Dalfrà, MG, Bertolotto, A, Mantaj, U, Wender-Ozegowska, E, Zawiejska, A, Hill, D, Jelsma, JGM, Snoek, FJ, Worda, C, Bancher-Todesca, D, van Poppel, MNM, Kautzky-Willer, A, Dunne, FP & DALI Core Investigator Group 2017, 'Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe', Diabetologia, vol. 60, no. 10, pp. 1913-1921. https://doi.org/10.1007/s00125-017-4353-9

APA

Egan, A. M., Vellinga, A., Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., ... DALI Core Investigator Group (2017). Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia, 60(10), 1913-1921. https://doi.org/10.1007/s00125-017-4353-9

Vancouver

Egan AM, Vellinga A, Harreiter J, Simmons D, Desoye G, Corcoy R et al. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia. 2017 Oct;60(10):1913-1921. https://doi.org/10.1007/s00125-017-4353-9

Author

Egan, Aoife M ; Vellinga, Akke ; Harreiter, Jürgen ; Simmons, David ; Desoye, Gernot ; Corcoy, Rosa ; Adelantado, Juan M ; Devlieger, Roland ; Van Assche, Andre ; Galjaard, Sander ; Damm, Peter ; Mathiesen, Elisabeth R ; Jensen, Dorte M ; Andersen, Liselotte ; Lapolla, Annuziata ; Dalfrà, Maria G ; Bertolotto, Alessandra ; Mantaj, Urszula ; Wender-Ozegowska, Ewa ; Zawiejska, Agnieszka ; Hill, David ; Jelsma, Judith G M ; Snoek, Frank J ; Worda, Christof ; Bancher-Todesca, Dagmar ; van Poppel, Mireille N M ; Kautzky-Willer, Alexandra ; Dunne, Fidelma P ; DALI Core Investigator Group. / Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. In: Diabetologia. 2017 ; Vol. 60, No. 10. pp. 1913-1921.

Bibtex

@article{9d58fde13aa84e5785842232791e5851,
title = "Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe",
abstract = "AIMS/HYPOTHESIS: Accurate prevalence estimates for gestational diabetes mellitus (GDM) among pregnant women in Europe are lacking owing to the use of a multitude of diagnostic criteria and screening strategies in both high-risk women and the general pregnant population. Our aims were to report important risk factors for GDM development and calculate the prevalence of GDM in a cohort of women with BMI ≥29 kg/m(2) across 11 centres in Europe using the International Association of the Diabetes and Pregnancy Study Groups (IADPSG)/WHO 2013 diagnostic criteria.METHODS: Pregnant women (n = 1023, 86.3{\%} European ethnicity) with a BMI ≥29.0 kg/m(2) enrolled into the Vitamin D and Lifestyle Intervention for GDM Prevention (DALI) pilot, lifestyle and vitamin D studies of this pan-European multicentre trial, attended for an OGTT during pregnancy. Demographic, anthropometric and metabolic data were collected at enrolment and throughout pregnancy. GDM was diagnosed using IADPSG/WHO 2013 criteria. GDM treatment followed local policies.RESULTS: The number of women recruited per country ranged from 80 to 217, and the dropout rate was 7.1{\%}. Overall, 39{\%} of women developed GDM during pregnancy, with no significant differences in prevalence across countries. The prevalence of GDM was high (24{\%}; 242/1023) in early pregnancy. Despite interventions used in the DALI study, a further 14{\%} (94/672) had developed GDM when tested at mid gestation (24-28 weeks) and 13{\%} (59/476) of the remaining cohort at late gestation (35-37 weeks). Demographics and lifestyle factors were similar at baseline between women with GDM and those who maintained normal glucose tolerance. Previous GDM (16.5{\%} vs 7.9{\%}, p = 0.002), congenital malformations (6.4{\%} vs 3.3{\%}, p = 0.045) and a baby with macrosomia (31.4{\%} vs 17.9{\%}, p = 0.001) were reported more frequently in those who developed GDM. Significant anthropometric and metabolic differences were already present in early pregnancy between women who developed GDM and those who did not.CONCLUSIONS/INTERPRETATION: The prevalence of GDM diagnosed by the IADPSG/WHO 2013 GDM criteria in European pregnant women with a BMI ≥29.0 kg/m(2) is substantial, and poses a significant health burden to these pregnancies and to the future health of the mother and her offspring. Uniform criteria for GDM diagnosis, supported by robust evidence for the benefits of treatment, are urgently needed to guide modern GDM screening and treatment strategies.",
keywords = "Journal Article",
author = "Egan, {Aoife M} and Akke Vellinga and J{\"u}rgen Harreiter and David Simmons and Gernot Desoye and Rosa Corcoy and Adelantado, {Juan M} and Roland Devlieger and {Van Assche}, Andre and Sander Galjaard and Peter Damm and Mathiesen, {Elisabeth R} and Jensen, {Dorte M} and Liselotte Andersen and Annuziata Lapolla and Dalfr{\`a}, {Maria G} and Alessandra Bertolotto and Urszula Mantaj and Ewa Wender-Ozegowska and Agnieszka Zawiejska and David Hill and Jelsma, {Judith G M} and Snoek, {Frank J} and Christof Worda and Dagmar Bancher-Todesca and {van Poppel}, {Mireille N M} and Alexandra Kautzky-Willer and Dunne, {Fidelma P} and {DALI Core Investigator Group}",
year = "2017",
month = "10",
doi = "10.1007/s00125-017-4353-9",
language = "English",
volume = "60",
pages = "1913--1921",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe

AU - Egan, Aoife M

AU - Vellinga, Akke

AU - Harreiter, Jürgen

AU - Simmons, David

AU - Desoye, Gernot

AU - Corcoy, Rosa

AU - Adelantado, Juan M

AU - Devlieger, Roland

AU - Van Assche, Andre

AU - Galjaard, Sander

AU - Damm, Peter

AU - Mathiesen, Elisabeth R

AU - Jensen, Dorte M

AU - Andersen, Liselotte

AU - Lapolla, Annuziata

AU - Dalfrà, Maria G

AU - Bertolotto, Alessandra

AU - Mantaj, Urszula

AU - Wender-Ozegowska, Ewa

AU - Zawiejska, Agnieszka

AU - Hill, David

AU - Jelsma, Judith G M

AU - Snoek, Frank J

AU - Worda, Christof

AU - Bancher-Todesca, Dagmar

AU - van Poppel, Mireille N M

AU - Kautzky-Willer, Alexandra

AU - Dunne, Fidelma P

AU - DALI Core Investigator Group

PY - 2017/10

Y1 - 2017/10

N2 - AIMS/HYPOTHESIS: Accurate prevalence estimates for gestational diabetes mellitus (GDM) among pregnant women in Europe are lacking owing to the use of a multitude of diagnostic criteria and screening strategies in both high-risk women and the general pregnant population. Our aims were to report important risk factors for GDM development and calculate the prevalence of GDM in a cohort of women with BMI ≥29 kg/m(2) across 11 centres in Europe using the International Association of the Diabetes and Pregnancy Study Groups (IADPSG)/WHO 2013 diagnostic criteria.METHODS: Pregnant women (n = 1023, 86.3% European ethnicity) with a BMI ≥29.0 kg/m(2) enrolled into the Vitamin D and Lifestyle Intervention for GDM Prevention (DALI) pilot, lifestyle and vitamin D studies of this pan-European multicentre trial, attended for an OGTT during pregnancy. Demographic, anthropometric and metabolic data were collected at enrolment and throughout pregnancy. GDM was diagnosed using IADPSG/WHO 2013 criteria. GDM treatment followed local policies.RESULTS: The number of women recruited per country ranged from 80 to 217, and the dropout rate was 7.1%. Overall, 39% of women developed GDM during pregnancy, with no significant differences in prevalence across countries. The prevalence of GDM was high (24%; 242/1023) in early pregnancy. Despite interventions used in the DALI study, a further 14% (94/672) had developed GDM when tested at mid gestation (24-28 weeks) and 13% (59/476) of the remaining cohort at late gestation (35-37 weeks). Demographics and lifestyle factors were similar at baseline between women with GDM and those who maintained normal glucose tolerance. Previous GDM (16.5% vs 7.9%, p = 0.002), congenital malformations (6.4% vs 3.3%, p = 0.045) and a baby with macrosomia (31.4% vs 17.9%, p = 0.001) were reported more frequently in those who developed GDM. Significant anthropometric and metabolic differences were already present in early pregnancy between women who developed GDM and those who did not.CONCLUSIONS/INTERPRETATION: The prevalence of GDM diagnosed by the IADPSG/WHO 2013 GDM criteria in European pregnant women with a BMI ≥29.0 kg/m(2) is substantial, and poses a significant health burden to these pregnancies and to the future health of the mother and her offspring. Uniform criteria for GDM diagnosis, supported by robust evidence for the benefits of treatment, are urgently needed to guide modern GDM screening and treatment strategies.

AB - AIMS/HYPOTHESIS: Accurate prevalence estimates for gestational diabetes mellitus (GDM) among pregnant women in Europe are lacking owing to the use of a multitude of diagnostic criteria and screening strategies in both high-risk women and the general pregnant population. Our aims were to report important risk factors for GDM development and calculate the prevalence of GDM in a cohort of women with BMI ≥29 kg/m(2) across 11 centres in Europe using the International Association of the Diabetes and Pregnancy Study Groups (IADPSG)/WHO 2013 diagnostic criteria.METHODS: Pregnant women (n = 1023, 86.3% European ethnicity) with a BMI ≥29.0 kg/m(2) enrolled into the Vitamin D and Lifestyle Intervention for GDM Prevention (DALI) pilot, lifestyle and vitamin D studies of this pan-European multicentre trial, attended for an OGTT during pregnancy. Demographic, anthropometric and metabolic data were collected at enrolment and throughout pregnancy. GDM was diagnosed using IADPSG/WHO 2013 criteria. GDM treatment followed local policies.RESULTS: The number of women recruited per country ranged from 80 to 217, and the dropout rate was 7.1%. Overall, 39% of women developed GDM during pregnancy, with no significant differences in prevalence across countries. The prevalence of GDM was high (24%; 242/1023) in early pregnancy. Despite interventions used in the DALI study, a further 14% (94/672) had developed GDM when tested at mid gestation (24-28 weeks) and 13% (59/476) of the remaining cohort at late gestation (35-37 weeks). Demographics and lifestyle factors were similar at baseline between women with GDM and those who maintained normal glucose tolerance. Previous GDM (16.5% vs 7.9%, p = 0.002), congenital malformations (6.4% vs 3.3%, p = 0.045) and a baby with macrosomia (31.4% vs 17.9%, p = 0.001) were reported more frequently in those who developed GDM. Significant anthropometric and metabolic differences were already present in early pregnancy between women who developed GDM and those who did not.CONCLUSIONS/INTERPRETATION: The prevalence of GDM diagnosed by the IADPSG/WHO 2013 GDM criteria in European pregnant women with a BMI ≥29.0 kg/m(2) is substantial, and poses a significant health burden to these pregnancies and to the future health of the mother and her offspring. Uniform criteria for GDM diagnosis, supported by robust evidence for the benefits of treatment, are urgently needed to guide modern GDM screening and treatment strategies.

KW - Journal Article

U2 - 10.1007/s00125-017-4353-9

DO - 10.1007/s00125-017-4353-9

M3 - Journal article

C2 - 28702810

VL - 60

SP - 1913

EP - 1921

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -

ID: 184909584